Our Approach
The unique properties of the eye make it an ideal setting for engineered cell-based therapeutics and in vivo reprogamming. New techniques enable Tenpoint to replace lost or damaged cells, potentially restoring their function with a single, long-lasting treatment that reverses the course of disease.
Our Journey
Founded by experts from leading institutions in ocular disease including Moorfields Eye Hospital, UCL Institute of Ophthalmology, Institut de la Vision and University of Washington, we have assembled a team with specific experience across a range of ocular diseases, and access to advancements across the spectrum of regenerative biology technologies.